Back to the future: testing in disseminated intravascular coagulation
Cancer procoagulant in patients with adenocarcinomas
Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study
Platelet hyper-function in acute coronary syndromes
No impact of factor IX Ala-10 mutations in acenocoumarol-treated southern Europeans
Phlegmasia cerulea dolens as a complication of deep vein thrombosis in a man with primary antiphospholipid syndrome
Efficacy of Haemate-P as prophylaxis of recurrent bleeding in a patient with type 2B von Willebrand's disease
Successful use of recombinant activated factor VII in the treatment of vitreous haemorrhage: a report of seven cases
A new optimized method for the determination of fibrin clot permeability
Identifying hypocoagulable states with a modified global assay of overall haemostasis potential in plasma
Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors
Cleavage of von Willebrand factor by ADAMTS-13 in vitro: effect of temperature and barium ions on the proteolysis kinetics
An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastography
Venous and arterial thrombosis following administration of intravenous immunoglobulins: reply to Feuillet and colleagues